Oligodendroglia Generated From Adult Rat Adipose Tissue by Direct Cell Conversion.
Lara Vellosillo1,2, Jorge Pascual-Guerra1, Maria Paz Muñoz1
1Servicio de Neurobiología-Investigación, IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Frontiers in Cell and Developmental Biology
|February 28, 2022
Summary
Researchers converted adult rat adipose-derived mesenchymal cells into functional oligodendrocyte precursor cells (OPCs). This direct phenotypic conversion offers a promising source for cell replacement therapies in demyelinating diseases.
Area of Science:
- Stem Cell Biology
- Neuroscience
- Regenerative Medicine
Background:
- Oligodendrocytes are crucial for myelin sheath formation and maintenance in the central nervous system.
- Demyelinating diseases, such as multiple sclerosis, result in oligodendrocyte loss and neurological deficits.
- Generating oligodendrocyte precursor cells (OPCs) from accessible tissues is vital for cell-based therapies.
Purpose of the Study:
- To investigate the feasibility of generating OPCs from adult rat adipose-derived mesenchymal stem cells.
- To determine the key transcription factors required for oligodendroglial differentiation.
- To assess the functional characteristics and therapeutic potential of converted OPCs.
Main Methods:
- Adipose-derived mesenchymal cells were transduced with tetracycline-inducible transcription factor genes (Sox10, Olig2, Zfp536, Nkx6.1).
- Immunostaining (O4 antibody) was used to identify and quantify oligodendroglial induction.
- Functional assays included receptor expression analysis and co-culture with neurons.
Main Results:
- A combination of Sox10, Olig2, and Zfp536 successfully induced O4-positive OPCs from mesenchymal cells.
- Converted cells exhibited progressive oligodendroglial markers and functional properties of neural-derived OPCs.
- Co-culture demonstrated the ability of converted cells to differentiate and ensheathe axons.
Conclusions:
- Direct phenotypic conversion of adult mesenchymal stem cells into functional oligodendroglia is achievable.
- This method provides a potential autologous cell source for treating demyelinating diseases.
- Continuous transgene expression is necessary to maintain the glial phenotype of converted cells.


